Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of the company Steady Medical (300888), including stock price movements and funding flows [1][2]. - As of January 7, 2026, Steady Medical's stock closed at 38.6 yuan, down 1.08%, with a trading volume of 47,000 hands and a transaction amount of 182 million yuan [1]. - In terms of funding flow on January 7, 2026, the main capital saw a net inflow of 6.1 million yuan, accounting for 3.35% of the total transaction amount, while retail investors experienced a net outflow of 123,700 yuan, representing 0.07% of the total [1]. Group 2 - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% [2]. - The third quarter of 2025 alone saw a main revenue of 2.601 billion yuan, reflecting a year-on-year growth of 27.71%, with a net profit of 240 million yuan, increasing by 42.11% [2]. - The company has a debt ratio of 33.87%, with investment income of 33.23 million yuan and a gross profit margin of 48.32% [2].
股票行情快报:稳健医疗(300888)1月7日主力资金净买入610.21万元